Cylex Announces Plan For Multi-Center Trial Of ImmuKnow(R) Assay In South Korea

September 1st, 2008 by admin

“Cylex, Inc., in connexion with our Asiatic distributor, Sun Woo Biotech, is delighted to be healthy to foretell our hold for a major, multi-center effort of the ImmuKnow assessment for cell-mediated status at heptad highly reputable scrutiny institutions in the Republic of Korea,” expressed Brad Stewart, chair of Cylex.

Tags:

Posted in Immunology |

Related posts

Comments are closed.